Visit the jardiance site for formulary decision makers to learn about the kdigo clinical practice guidelines See isi, pi, and med guide. My local nephrologist said jardiance is used for the same purpose I have ckd as a part of having idiopathic immunotactoid glomerulopathy On the other hand, i have serious proteinuria, a hallmark of itg (my nephrologist writes i am at stage 2/3 in appt
Chronic kidney disease guidelines and disease modifying therapy have seen a dramatic shift in the last 5 years The sglt2 inhibitor class of medications has been catapulted from hyperglycemia management medications, to cardiovascular and kidney. The fda has approved jardiance to reduced the risk of kidney disease progression and cardiovascular death in chronic kidney disease. It is also approved to improve glycemic control in patients ≥10 years old with. View isi, pi, and med guide. Regulatory agencies across the world have recommended empagliflozin (trade name jardiance®) for the treatment of adults with chronic kidney disease (ckd)
In the active trial, patients with chronic kidney disease were randomly assigned to receive either empagliflozin (10 mg once daily) or matching placebo and were followed for a median of 2 years.
WATCH
